Smith Salley Wealth Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $929K | Sell |
8,982
-113
| -1% | -$10.1K | 0.04% | 161 |
|
|
2026
Q1 | $653K | Sell |
9,095
-18
| -0.2% | -$1.39K | 0.03% | 176 |
|
|
2025
Q4 | $723K | Sell |
9,113
-143
| -2% | -$11.3K | 0.04% | 172 |
|
|
2025
Q3 | $698K | Buy |
9,256
+254
| +3% | +$17.4K | 0.04% | 171 |
|
|
2025
Q2 | $621K | Buy |
9,002
+275
| +3% | +$18K | 0.04% | 170 |
|
|
2025
Q1 | $591K | Sell |
8,727
-8,127
| -48% | -$486K | 0.04% | 165 |
|
|
2024
Q4 | $757K | Sell |
16,854
-2,184
| -11% | -$123K | 0.05% | 154 |
|
|
2024
Q3 | $1.2M | Sell |
19,038
-1,106
| -5% | -$64.5K | 0.08% | 129 |
|
|
2024
Q2 | $1.19M | Buy |
+20,144
| New | +$1.26M | 0.09% | 126 |
|
|
2020
Q1 | – | Sell |
-2,897
| Closed | -$215K | – | 184 |
|
|
2019
Q4 | $215K | Buy |
+2,897
| New | +$203K | 0.03% | 189 |
|
|
2019
Q1 | – | Sell |
-3,171
| Closed | -$208K | – | 176 |
|
|
2018
Q4 | $208K | Buy |
3,171
+62
| +2% | +$4.63K | 0.04% | 164 |
|
|
2018
Q3 | $245K | Buy |
+3,109
| New | +$222K | 0.04% | 169 |
|
|
2017
Q4 | – | Sell |
-57,008
| Closed | -$4.63M | – | 182 |
|
|
2017
Q3 | $4.63M | Buy |
57,008
+1,416
| +3% | +$112K | 0.89% | 42 |
|
|
2017
Q2 | $4.47M | Sell |
55,592
-409
| -0.7% | -$32.3K | 0.9% | 42 |
|
|
2017
Q1 | $4.4M | Sell |
56,001
-892
| -2% | -$71.2K | 0.9% | 42 |
|
|
2016
Q4 | $4.49M | Buy |
56,893
+1,060
| +2% | +$85.8K | 0.93% | 40 |
|
|
2016
Q3 | $4.97M | Buy |
55,833
+748
| +1% | +$70.6K | 1.1% | 36 |
|
|
2016
Q2 | $5.27M | Buy |
55,085
+2,124
| +4% | +$212K | 1.23% | 31 |
|
|
2016
Q1 | $5.49M | Buy |
52,961
+1,692
| +3% | +$165K | 1.38% | 26 |
|
|
2015
Q4 | $5.01M | Buy |
51,269
+782
| +2% | +$76.6K | 1.25% | 29 |
|
|
2015
Q3 | $4.87M | Buy |
50,487
+698
| +1% | +$73.4K | 1.31% | 28 |
|
|
2015
Q2 | $5.22M | Buy |
49,789
+1,000
| +2% | +$102K | 1.33% | 28 |
|
|
2015
Q1 | $5.04M | Buy |
48,789
+2,711
| +6% | +$274K | 1.28% | 27 |
|
|
2014
Q4 | $4.44M | Buy |
46,078
+5,360
| +13% | +$472K | 1.15% | 32 |
|
|
2014
Q3 | $3.24M | Buy |
40,718
+4,235
| +12% | +$334K | 0.86% | 41 |
|
|
2014
Q2 | $2.75M | Buy |
36,483
+7,101
| +24% | +$537K | 0.73% | 51 |
|
|
2014
Q1 | $2.2M | Sell |
29,382
-151
| -0.5% | -$10.7K | 1.38% | 27 |
|
|
2013
Q4 | $2.11M | Buy |
29,533
+317
| +1% | +$20.4K | 1.38% | 33 |
|
|
2013
Q3 | $1.66M | Buy |
29,216
+715
| +3% | +$42.6K | 1.34% | 38 |
|
|
2013
Q2 | $1.63M | Buy |
+28,501
| New | +$1.65M | 1.31% | 36 |
|
Other funds holding CVS
LMFP
CF
HCM
FWIA
MIF
Smith Salley Wealth Management's CVS Position: Q2 2026 in Review
Smith Salley Wealth Management reduced its CVS Health (CVS) stake by 1.2% in Q2 2026, selling an estimated $10.1K and leaving 8,982 shares worth $929K. The position accounts for 0.04% of the portfolio, ranked #161.
Smith Salley Wealth Management first reported a position in CVS in Q2 2013 and has held it in 30 quarters since. The position peaked at $5.49M in Q1 2016. 650 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Smith Salley Wealth Management held 8,982 shares of CVS Health worth $929K as of Q2 2026.
- Smith Salley Wealth Management sold 113 CVS Health shares in Q2 2026, an estimated $10.1K.
- CVS Health made up 0.04% of Smith Salley Wealth Management's portfolio in Q2 2026, its #161 holding.
- Smith Salley Wealth Management first reported a position in CVS Health in Q2 2013 and has held it in 30 quarters since.
- Smith Salley Wealth Management's CVS Health position peaked at $5.49M in Q1 2016.
- 650 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Smith Salley Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.